---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "dbaHBFm4kAdrgr7s40Y3otPDDD3uybjjHcgeBJWVCTeaOwFzu8HJOkFy3daflky8SwuZgv9svCGoVQXWzc1HjWFtzLGbubHsvVGBbzJoV1UusvSMA+0Z3S533kJULtY2v9AS46oOoDUrbZWiXxB43wvpePE9qEUx2Hv1NO9PcDjhhJAb/OfBoMkeSh57vFlyOF4L520yAETklPaofWZXA9P7AHIylupdJlDiYURU21qErk1qKiMKZtSVtKPU84sHbRtd9XeGiBMrtARa1gmIlPrpOPs/olPlGpKoVKf56ztbd2dgbT7YA4RwYZ3AICavPLXA94JEAUn0U+HD1+vDWk9CH1CT6PXqignf9WGV/K4=;ohlQJBUv7+8EAC2K4AWNIQ=="
---

